Piramal Pharma Consumer Products Division launches in-house D2C platform Wellify.in

The platform shall provide consumers' access to its entire range of products across more than 20 brands along with all the new offerings that company is going to launch in future

author-image
BestMediaInfo Bureau
Updated On
New Update
Piramal Pharma Consumer Products Division launches in-house D2C platform Wellify.in

Piramal Pharma Limited Consumer Products Division (CPD) has announced the launch of its D2C platform, Wellify.in.

As per the company, it is an exclusive, one-stop shop for all the health and wellness brand offerings by the company, and is expected to contribute 10% of the e-commerce business in terms of revenue by end of FY24.

The platform shall provide consumers’ access to its entire range of products across more than 20 brands along with all the new offerings that company is going to launch in future. The platform would offer products across various categories such as health and wellness, beauty, baby care and toys and women’s intimate range. 

Wellify promises to serve consumers better by giving them direct-to-home access to highly effective and quality products from Piramal, that are trusted by millions of consumers across the country.

As per the company, the platform will offer free home delivery, no minimum order value and delightful offers which will enable rise in daily orders. Wellify is designed to offer personalised experience to the users powered by advanced technology as Piramal CPD has invested in Martech tools to offer superlative experience to its consumers. 

Nitish Bajaj, CEO and Piramal Consumer Product Division, commented, “E-commerce has exploded in the country and has been a major growth engine for our business as well. With the launch of our D2C platform, Wellify.in, we are looking at bolstering our e-commerce capabilities by reaching out to our customers directly with quality products, customised offerings and multiple delivery options. We have heavily invested in e-commerce in the last two years which is poised for a significant growth and is expected to contribute to 25% of our overall revenue in next 3 years.”

Info@BestMediaInfo.com

Piramal Piramal Pharma Wellify Nitish Bajaj Consumer Products.
Advertisment